Neurogene Inc (NGNE)
34.50
+2.49
(+7.78%)
USD |
NASDAQ |
Jun 27, 10:39
Neurogene Price: 34.50 for June 27, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Jun 26, 2024 | 30.87 | 32.65 | 30.15 | 32.01 | 117312.0 |
Jun 25, 2024 | 31.62 | 32.62 | 31.01 | 31.10 | 111940.0 |
Jun 24, 2024 | 30.80 | 32.53 | 30.80 | 31.75 | 73120.00 |
Jun 21, 2024 | 31.30 | 31.53 | 30.07 | 31.01 | 156137.0 |
Jun 20, 2024 | 30.50 | 31.43 | 29.89 | 31.07 | 230040.0 |
Jun 18, 2024 | 38.71 | 39.99 | 29.69 | 30.32 | 209265.0 |
Jun 17, 2024 | 43.25 | 44.52 | 39.89 | 40.00 | 84677.00 |
Jun 14, 2024 | 42.00 | 43.06 | 39.41 | 42.59 | 85866.00 |
Jun 13, 2024 | 37.12 | 42.57 | 37.12 | 41.99 | 248155.0 |
Jun 12, 2024 | 37.35 | 38.40 | 36.72 | 37.18 | 48696.00 |
Jun 11, 2024 | 37.89 | 37.89 | 36.16 | 37.18 | 43933.00 |
Jun 10, 2024 | 37.31 | 38.62 | 37.31 | 37.35 | 36422.00 |
Jun 07, 2024 | 36.62 | 38.10 | 36.51 | 37.88 | 22570.00 |
Jun 06, 2024 | 37.12 | 38.07 | 36.40 | 37.16 | 65948.00 |
Jun 05, 2024 | 37.69 | 39.08 | 37.01 | 37.47 | 48886.00 |
Jun 04, 2024 | 37.75 | 38.59 | 36.50 | 37.73 | 45987.00 |
Jun 03, 2024 | 38.00 | 38.96 | 35.07 | 37.23 | 62937.00 |
May 31, 2024 | 34.68 | 38.33 | 34.32 | 37.60 | 138019.0 |
May 30, 2024 | 33.09 | 34.21 | 32.45 | 34.03 | 56149.00 |
May 29, 2024 | 31.27 | 33.64 | 31.00 | 33.34 | 53790.00 |
May 28, 2024 | 32.62 | 32.80 | 31.00 | 31.71 | 72000.00 |
May 24, 2024 | 31.49 | 32.93 | 31.06 | 32.11 | 48817.00 |
May 23, 2024 | 32.89 | 33.26 | 31.08 | 31.49 | 40122.00 |
May 22, 2024 | 32.53 | 33.85 | 31.77 | 32.40 | 44842.00 |
May 21, 2024 | 34.03 | 34.03 | 31.18 | 32.52 | 181911.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
8.048
Minimum
Nov 16 2022
341.00
Maximum
Jun 23 2020
105.40
Average
56.20
Median
Oct 02 2019
Price Benchmarks
Taysha Gene Therapies Inc | 2.115 |
CEL-SCI Corp | 1.18 |
AIM ImmunoTech Inc | 0.3754 |
IGC Pharma Inc | 0.43 |
NovaBay Pharmaceuticals Inc | 2.17 |
Price Related Metrics
Price to Book Value | 2.622 |
Earnings Yield | -78.92% |
Market Cap | 447.82M |